Table 2.
mRNA expression of investigated genes in tissue samples from the patient
Specimen | CALM2 | KRT5 | KRT20 | ERBB2 | FGFR1 | FGFER3 |
---|---|---|---|---|---|---|
Healthy bladder tissue | 26.82 | 34.47 | 35.98 | 37.39 | 35.75 | 36.95 |
Primary bladder tumor | 26.57 | 36.52 | 40.79 | 39.33 | 32.36 | 41.02 |
Recurrent bladder tumor | 25.32 | 37.56 | 40.33 | 39.78 | 32.64 | 41.26 |
Liver metastasisa | 34.49 | 40.31 | 38.41 | 38.94 | 35.28 | 41.03 |
Bone metastasisa | 34.79 | 36.20 | 40.16 | 39.53 | ND | 39.59 |
Lymph nodea | 33.19 | 35.27 | 39.72 | 35.76 | 34.91 | 39.86 |
Right uretera | 34.45 | 38.55 | ND | 37.13 | 35.15 | 40.03 |
ND = not detected.
Bold values represent tumor associated overexpressions among investigated genes and were used to emphazise this aspect.
Obtained from autopsy.